Drugs and Devices

The Avandia saga

Read an interesting editorial about Avandia here. A U.S. Food and Drug Administration panel recommended keeping the drug on the market, but increasing warnings about the drug’s potential to increase risk for heart attacks.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares